CoreCap Advisors’s Fulgent Genetics FLGT Stock Holding History

CoreCap Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.1K	Hold	50	–	–	﹤0.01%	2644
2026 Q2	$1.03K	Hold	50	–	–	﹤0.01%	2688
2026 Q1	$795	Hold	50	–	–	﹤0.01%	2567
2025 Q4	$1.31K	Buy	+50	New	+$1.3K	﹤0.01%	2553
2025 Q1	–	Sell	-20	Closed	-$369	–	3190
2024 Q4	$369	Buy	20 +8	+67%	+$156	﹤0.01%	2594
2024 Q3	$261	Buy	+12	New	+$268	﹤0.01%	2456
2022 Q3	–	Sell	-164	Closed	-$9K	–	1062
2022 Q2	$9K	Buy	+164	New	+$9.01K	﹤0.01%	1504
2022 Q1	–	Sell	-264	Closed	-$27K	–	1067
2021 Q4	$27K	Buy	+264	New	+$23.2K	﹤0.01%	1218

Other funds holding FLGT

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

ATC

Adirondack Trust Company Saratoga Springs, New York $320M AUM 23.25% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

TCM

Triumph Capital Management Denver, Colorado $573M AUM 15.32% 1-Year Est. Return

CoreCap Advisors's FLGT Position: Q3 2026 in Review

CoreCap Advisors held its Fulgent Genetics (FLGT) position steady in Q3 2026 at 50 shares worth $1.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2644.

CoreCap Advisors first reported a position in FLGT in Q4 2021 and has held it in 8 quarters since. The position peaked at $27K in Q4 2021. 10 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.

CoreCap Advisors held 50 shares of Fulgent Genetics worth $1.1K as of Q3 2026.
CoreCap Advisors left its Fulgent Genetics share count unchanged in Q3 2026.
Fulgent Genetics made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2644 holding.
CoreCap Advisors first reported a position in Fulgent Genetics in Q4 2021 and has held it in 8 quarters since.
CoreCap Advisors's Fulgent Genetics position peaked at $27K in Q4 2021.
10 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.